Ancora Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Ancora Advisors’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14	Closed	-$1.01K	–	1854
2023 Q1	$1.01K	Buy	+14	New	+$995	﹤0.01%	1626
2021 Q2	–	Sell	-240	Closed	-$23K	–	1974
2021 Q1	$23K	Hold	240	–	–	﹤0.01%	1267
2020 Q4	$15K	Hold	240	–	–	﹤0.01%	1122
2020 Q3	$14K	Hold	240	–	–	﹤0.01%	1079
2020 Q2	$17K	Hold	240	–	–	﹤0.01%	1019
2020 Q1	$11K	Hold	240	–	–	﹤0.01%	1163
2019 Q4	$16K	Buy	+240	New	+$16K	﹤0.01%	1099
2018 Q4	–	Sell	-240	Closed	-$41K	–	954
2018 Q3	$41K	Buy	+240	New	+$36.2K	﹤0.01%	934
2017 Q1	–	Sell	-240	Closed	-$15K	–	884
2016 Q4	$15K	Buy	+240	New	+$15.1K	﹤0.01%	991

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Ancora Advisors's LGND Position: Q2 2023 in Review

Ancora Advisors sold out of Ligand Pharmaceuticals (LGND) in Q2 2023, closing a stake of 14 shares — an estimated $1.01K sold.

Ancora Advisors first reported a position in LGND in Q4 2016 and held it in 9 quarters. The position peaked at $41K in Q3 2018. 204 funds tracked by Wall St. Rank hold LGND as of Q2 2023.

Ancora Advisors reported no remaining Ligand Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Ancora Advisors sold 14 Ligand Pharmaceuticals shares in Q2 2023, an estimated $1.01K.
Ancora Advisors first reported a position in Ligand Pharmaceuticals in Q4 2016 and held it in 9 quarters.
Ancora Advisors's Ligand Pharmaceuticals position peaked at $41K in Q3 2018.
204 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2023.

Based on Ancora Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.